Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06361173
Other study ID # STUDY00004127
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date June 1, 2024
Est. completion date May 1, 2026

Study information

Verified date April 2024
Source Nationwide Children's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective of this project is to trans-create, conduct user testing of a previously developed and piloted mHealth app, and user acceptability with parents of children in the acute phase post-allogeneic hematopoietic stem cell transplant (HSCT). Nationwide Children's Hospital (NCH) will be the primary data collection site and Columbia University Irving Medical Center will be a secondary site.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date May 1, 2026
Est. primary completion date May 1, 2026
Accepts healthy volunteers No
Gender All
Age group 0 Years to 17 Years
Eligibility Inclusion Criteria: Eligible caregivers must have children who: 1. Are 0-17 years old 2. Underwent HCT 3. Are planned for discharge prior to day 100 post-transplant Primary caregivers must: 1. Be Spanish speaking 2. Be =18 years old 3. Have a smartphone (iOS or Android) capable of downloading apps Exclusion Criteria: (a) Children or caregivers with pre-existing neurodevelopmental disorder/disability or a pervasive developmental disorder will be excluded from this study.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
BMT4me
Caregivers will pilot test a Spanish version of the BMT4me app at a single time point.

Locations

Country Name City State
United States Nationwide Children's Hospital Columbus Ohio
United States Columbia University Irving Medical Center New York New York

Sponsors (2)

Lead Sponsor Collaborator
Nationwide Children's Hospital Columbia University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assess app usability using the System Usability Scale (SUS) Data collected using the System Usability Scale (SUS) will provide insight to the usability of the Spanish BMT4Me app in its current form. he SUS is a 10-item questionnaire routinely used to evaluate the functionality and acceptability of mHealth apps. The SUS is scored on a scale, giving a score from from 0 to 100 where 100 is considered the highest rating of usability. A score of > 68 is considered above average. 6/1/24 - 5/1/26
See also
  Status Clinical Trial Phase
Withdrawn NCT02451462 - Pilot Trial of Zoledronic Acid to Prevent Bone Loss in Hematopoietic Cell Transplant Recipients N/A
Completed NCT03654599 - Effects of Digital Stories Intervention on Psychosocial Well-being N/A
Active, not recruiting NCT04395222 - Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation Phase 2
Not yet recruiting NCT05603156 - A Study of Olverembatinib Combined With Inotuzumab Ozogamicin in the Treatment ph+ ALL With MRD Persistent Positive N/A
Completed NCT03530969 - Geriatric Communication Skills Training Program for Oncology Clinicians N/A
Recruiting NCT04115241 - Activity Levels in Bone Marrow Transplant Patients
Completed NCT00143780 - Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination Phase 4
Completed NCT05662631 - Remote Monitoring and Home-based Health Care for Treatment of Bone Marrow Transplant Patients N/A
Completed NCT03028961 - Stanford Letter or Traditional Advance Directive in Advance Care Planning in Patients Undergoing Bone Marrow Transplant N/A
Completed NCT02575079 - Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCT N/A
Active, not recruiting NCT02665065 - Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia Phase 3
Completed NCT01735565 - Neutrophil Extracellular Trap Formation in Patients Undergoing Bone Marrow Transplant N/A
Completed NCT04041219 - Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients Phase 4
Completed NCT03030248 - Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients Phase 2
Completed NCT00695123 - Screening for Subjects to Participate in Studies of Blood Disorders
Terminated NCT02057289 - A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis Phase 1
Completed NCT04275830 - The Effects of Heart Rate Variability Biofeedback Training on Hematopoietic Cell Transplantation Patients N/A
Completed NCT03902210 - BMT Online Wellness Study N/A
Completed NCT03245788 - Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study N/A
Completed NCT03758911 - Perspectives on Bone Marrow Donors Who Donate for Their Parent